1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Tumor Responses: new trials by email Literature Review of Tumor Responses trials Research Report on Tumor Responses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma Atorvastatin 10mg, Placebo Oral Tablet - Overall Survival, Tumor Responses | Phase 2 | Terminated | Taichung Veterans General Hospital | 34 | 2017-12-21 | 2021-03-16 |
| Dose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical Trial Lobaplatin, linear accelerator - Acute Toxic Effects, Tumor Responses | Phase 1 | Completed | Fifth Affiliated Hospital, Sun Yat-Sen University | 17 | 2016-06-22 | 2018-04-10 |
Atorvastatin (1) · Particle Accelerators (1) · lobaplatin (1)
Fifth Affiliated Hospital, Sun Yat-Sen University (1) · Taichung Veterans General Hospital (1)
China (1) · Taiwan (1)
Siyang Wang, bachelor (1) · Teng-Yu Lee, MD (1)